Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Large Cap
  • Markets
  • Price Target
  • Tech
  • Upgrades

Analyst Double Upgrades NVIDIA: Recognizes Potential To Cash On AI Opportunity

By Lekha Gupta
April 18, 1:02 PM
HSBC analyst Frank Lee double-upgraded NVIDIA Corp (NASDAQ:NVDA) to Buy from Reduce and increased the price target to $355 from $175. Lee…

MSFT

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

Why AstraZeneca Shares Are Trading Higher Today?

By Vandana Singh
April 18, 12:00 PM
AstraZeneca plc's (NASDAQ: AZN) vaccine head highlighted the confidence that the company's new COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants.

AZN

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Yet Again: Johnson & Johnson Subsidiary Seeks Stay On Thousands Of Cancer Lawsuits Associated With Talc Products

By Vandana Singh
April 18, 11:57 AM
Johnson & Johnson's (NYSE: JNJ) subsidiary, LTL Management, has reportedly requested a U.S. judge to delay 38,000 lawsuits again. These lawsuits accuse their baby powder and other talc products of causing cancer. 

JNJ

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

FDA Gives Green Signal To Second Omicron-Adapted Booster Shots For People At High Risk From Covid

By Vandana Singh
April 18, 11:53 AM
On Tuesday, the FDA amended the emergency use authorizations (EUAs) of Moderna Inc (NASDAQ:MRNA) and Pfizer Inc (NYSE:PFE), and BioNTech SE’s (NASDAQ:BNTX) COVID-19 bivalent mRNA vaccines…

BNTX

Read More
1 minute read
  • Equities
  • General
  • Guidance
  • Large Cap
  • Markets
  • News
  • Real Estate
  • REIT

Prologis Q1 Revenues Jump 45%; Says Remain Cautious Citing Macroenvironment

By Lekha Gupta
April 18, 11:25 AM
Logistics real estate firm Prologis Inc (NYSE:PLD) reported first quarter 2023 revenues of $1.77 billion, up 45%, on a continued strong…

PLD

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Rumors

Why Catalent Shares Are Falling Today

By Vandana Singh
April 18, 9:52 AM
Life-sciences company Danaher Corporation (NYSE:DHR) is reportedly no longer considering a takeover of contract manufacturer Catalent Inc (NYSE:CTLT) after expressing interest in…

CTLT

Read More
2 minute read
  • Earnings Beats
  • General
  • Large Cap
  • Markets
  • Movers
  • News

Goldman Sachs Clocks Mixed Q1 Performance, Investment Banking Falls 26%, Sees Net Gain In Credit Losses Provision

By Lekha Gupta
April 18, 9:03 AM
Goldman Sachs Inc (NYSE: GS) reported Q1 net revenues of

GS

Read More
2 minute read
  • Earnings
  • Earnings Beats
  • Large Cap
  • News
  • Pre-Market Outlook

Bank of America Outshines Projections: Q1 16% Earnings Beat Fuels Share Price Rally

By Piero Cingari
April 18, 8:48 AM
Bank of America (NYSE: BAC) outperforms expectations for the first quarter financial results, delivering a 16% positive surprise in earnings per share ($0.94 vs.

BAC

Read More
2 minute read
  • Earnings
  • Earnings Beats
  • Large Cap
  • Movers
  • News

Why Bank Of America Shares Are Gaining Today

By Akanksha Bakshi
April 18, 8:11 AM
Bank of America Corp (NYSE: BAC) shares are up 2% Tuesday morning following its solid first quarter results that surpassed the Street view.

BAC

Read More
1 minute read
  • Biotech
  • Dividends
  • Earnings
  • Earnings Beats
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Johnson & Johnson Q1 Beats Street View On Strong Performance Across All Segments, Lifts Guidance, Dividends

By Vandana Singh
April 18, 7:39 AM
Johnson & Johnson (NYSE:JNJ) has reported Q1 FY23 adjusted earnings of $2.68 per share, up 0.4% Y/Y and beating the…

JNJ

Posts pagination

Previous 1 … 332 333 334 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service